MB-207

N/A

Report date: 2024/11/26 14:38:31

Base Information

Drug NameMB-207
Drug Alias NameMB-207
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionInterleukin-2 receptor subunit gamma stimulants
TargetsInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsX-Linked Combined Immunodeficiency Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMustang Bio Inc
Active IndicationsN/A
Inactive IndicationsX-Linked Combined Immunodeficiency Diseases

Other Information

ATC CodeN/A
Related LinksN/A